{
    "clinical_study": {
        "@rank": "148224", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      I.  Determine the efficacy of alendronate sodium in treating osteopenia (generalized bone\n      density and focal bone lesions) in patients with Gaucher's disease."
        }, 
        "brief_title": "Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease", 
        "condition": [
            "Gaucher's Disease", 
            "Osteopenia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Gaucher Disease", 
                "Bone Diseases, Metabolic"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      This is a randomized, double blind, placebo controlled study.\n\n      All patients receive oral calcium carbonate and cholecalciferol daily. Patients are\n      randomized to receive oral alendronate sodium or placebo daily for 24 months.\n\n      Patients are followed every 6 months for 2 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics--\n\n        Diagnosis of type 1 Gaucher's disease enzymatically proven to have acid beta glucosidase\n        deficiency\n\n        Must have been on stable dose (8-60 U/kg/every 2 weeks) of alglucerase enzyme therapy\n        (Cerezyme or Ceredase) for at least 24 months\n\n        Lumbar spine bone density below the mean for age, sex, and race\n\n        --Prior/Concurrent Therapy--\n\n        At least 6 months since prior medications that directly affect skeletal metabolism\n        including, but not limited to, bisphosphonates, calcitonin, parathyroid hormone, or\n        estrogen\n\n        --Patient Characteristics--\n\n        Renal: No chronic renal failure; No recurrent renal stones\n\n        Esophageal: No history of dysphagia; No frequent heartburn; No esophagitis requiring\n        treatment\n\n        Other: No untreated hyperthyroidism or hypothyroidism; No concurrent hyperparathyroidism;\n        No concurrent malignancy; No history of alcohol or drug abuse; Not pregnant; Negative\n        pregnancy test; Fertile patients must use effective contraception"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "82", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004488", 
            "org_study_id": "199/14269", 
            "secondary_id": [
                "CHMC-C-FDR001537", 
                "CHMC-C-498"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "alendronate sodium", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "calcium carbonate", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "cholecalciferol", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Calcium Carbonate", 
                "Cholecalciferol", 
                "Alendronate"
            ]
        }, 
        "keyword": [
            "Gaucher's disease", 
            "inborn errors of metabolism", 
            "rare disease", 
            "sphingolipidoses"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "contact": {
                    "last_name": "Richard J. Wenstrup", 
                    "phone": "800-647-4805"
                }, 
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45229-3039"
                    }, 
                    "name": "Children's Hospital Medical Center - Cincinnati"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Shumei S. Guo", 
                    "phone": "513-873-2933"
                }, 
                "facility": {
                    "address": {
                        "city": "Dayton", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45401"
                    }, 
                    "name": "Wright State University School of Medicine"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Ari Zimran", 
                    "phone": "972-2-6555-111"
                }, 
                "facility": {
                    "address": {
                        "city": "Jerusalem", 
                        "country": "Israel", 
                        "zip": "91031"
                    }, 
                    "name": "Shaare Zedek Medical Center"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Israel"
            ]
        }, 
        "overall_official": {
            "affiliation": "Children's Hospital Medical Center, Cincinnati", 
            "last_name": "Richard J. Wenstrup", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004488"
        }, 
        "source": "FDA Office of Orphan Products Development", 
        "sponsors": {
            "collaborator": {
                "agency": "Children's Hospital Medical Center, Cincinnati", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "FDA Office of Orphan Products Development", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "October 1998", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2000"
    }, 
    "geocoordinates": {
        "Children's Hospital Medical Center - Cincinnati": "39.103 -84.512", 
        "Shaare Zedek Medical Center": "31.768 35.214", 
        "Wright State University School of Medicine": "39.759 -84.192"
    }
}